GlassScriptPhysician profile
Cheryl R Suiter
NPI 1093915142
$999.58
in general payments reported to CMS, 2019-2025
12 companies · $35.65 in 2025
The $35.65 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.82 · 2020: $91.31 · 2021: $451 · 2022: $196 · 2023: $145 · 2024: $61.24 · 2025: $35.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $320.46 | 2020-2023 | Lo Loestrin Fe, Liletta |
| Mayne Pharma Commercial LLC | $233.26 | 2021-2023 | |
| Therapeuticsmd, INC. | $105.81 | 2020-2022 | |
| Evofem Biosciences, INC. | $102.73 | 2021-2022 | |
| Exeltis, USA INC. | $79.57 | 2022-2025 | Slynd |
| Allergan, INC. | $36.34 | 2019-2020 | |
| Astellas Pharma US INC | $27.89 | 2024 | Veozah |
| Davol INC. | $22.65 | 2021 | |
| Exact Sciences Corporation | $20.69 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $19.70 | 2025 | Myosure Tissue Removal Device |
| Avion Pharmaceuticals | $15.43 | 2023 | Balcoltra |
| Shield Therapeutics INC | $15.05 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Suiter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.